LZTFL1 Inhibitors encompasses a diverse range of compounds that indirectly modulate the activity or functions of the LZTFL1 (Leucine Zipper Transcription Factor-Like 1) protein. These inhibitors do not interact directly with LZTFL1 but exert their influence through the modulation of various signaling pathways and molecular processes that are either upstream or downstream of LZTFL1 activity. The primary characteristic that unifies these chemicals is their capacity to interfere with cellular signaling networks and regulatory mechanisms, which, in turn, have a consequential impact on the functional dynamics of LZTFL1 within cellular systems. This group includes inhibitors of key signaling molecules and pathways, such as mTOR, Wnt, TGF-beta, ROCK, PI3K/AKT, MAPK/ERK, JNK, AMPK, NF-kB, and GSK-3. The inhibition of these pathways can result in alterations in cell proliferation, differentiation, and metabolism, thereby indirectly influencing the biological processes where LZTFL1 is implicated.
The mechanisms of action of these inhibitors are varied, demonstrating the complexity of cellular signaling and the interconnected nature of these pathways. For instance, compounds like Rapamycin target the mTOR pathway, crucial for cell growth and proliferation, while Wnt-C59 and IWP-2 disrupt Wnt signaling, pivotal in cell fate determination. Kinase inhibitors, such as LY294002, U0126, and SP600125, interfere with critical kinase-driven signaling cascades, namely PI3K/AKT, MAPK/ERK, and JNK pathways, respectively. Each of these inhibitors impacts specific cellular processes by either inhibiting enzyme activity, blocking protein-protein interactions, or hindering the production or function of key signaling molecules. This diverse arsenal of inhibitors enables the exploration of the various biological roles of LZTFL1, given its non-enzyme nature and involvement in complex protein networks. The study of these inhibitors offers insight into the molecular mechanisms governing cell behavior and the intricate web of intracellular signaling, highlighting the sophisticated orchestration of cellular functions at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, rapamycin can indirectly influence LZTFL1 by modulating downstream signaling pathways that may intersect with LZTFL1 functions. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
This Porcupine inhibitor blocks Wnt signaling, potentially affecting LZTFL1-related pathways due to the role of Wnt in cell fate and proliferation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A TGF-beta receptor inhibitor, it may impact LZTFL1 activity by altering TGF-beta signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
As a ROCK inhibitor, it could affect cytoskeletal dynamics and potentially influence LZTFL1-related processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, it modulates AKT signaling, potentially affecting pathways linked with LZTFL1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, it could affect signaling pathways that might intersect with LZTFL1 functions. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
This inhibitor of Wnt production may indirectly affect LZTFL1 by altering Wnt signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK inhibitor, it can modify signaling pathways potentially connected with LZTFL1. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
This AMPK inhibitor could have an indirect impact on LZTFL1 through metabolic signaling pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-kB inhibitor, it may influence cellular processes related to LZTFL1's function. | ||||||